Yusuke has given an opening synposium-'Development of novel small-molecule inhibitors targeting cancer-stem cells'
2/16 keynote lecture
Development of novel anti-cancer drugs targeting cancer stem cells.
2/17 Poster Session A
Germline PARP4 mutations in patients with primary thyroid and breast
Critical role of SMYD3-mediated methylation in the oncogenic activity of
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer
Significant growth suppressive effects of TOPK and MELK inhibitors in
2/18 Poster Session B
Yunus Emre Tarhan
GALNT6 is a novel molecular target in treatment of pancreatic cancer.
PRMT1 enhances formation of chromosomal passenger complex (CPC) through
arginine methylation of INCENP in human cancer cells.
T cell receptor repertoire predicts clinical response of neoadjuvant
chemotherapy in breast cancer.
2/19 Poster Session C
Identification of peptide-specific T cells in advanced colorectal cancer
patients treated with cancer peptide vaccines through deep TCR sequencing.
Tu H Mai
Quantitative Analysis and Clonal Characterization of T-cell Receptor Beta
Repertoires in Non-Small-Cell Lung Cancer Patients in a Phase II Clinical
Trial of a Novel Three-Peptide Vaccine.